Increased progesterone/estradiol ratio on the day of hCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone

Taiwanese Journal of Obstetrics and Gynecology

Volumn 47, Issue 2, 2008, Pages 168-174

  Ou, Yu Che ^a   Lan, Kuo Chung ^a,b   Chang, Shiuh Young ^a,b   Kung, Fu Tsai ^a,b   Huang, Fu Jen ^a,b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

GnRH agonist; Premature luteinization; Progesterone to estradiol ratio; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INFERTILITY; LUTEINIZATION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY CYCLE; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 47349111882     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)60075-3     Document Type: Article

References (33)

1. Hofmann GE, Khoury J, Michener C. Elevated serum prog-esterone-to- estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve. Fertil Steril 2002;78:47-50.
2. Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/ estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 2001;76:294-9.
3. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril 1 997;68:799-805.
4. Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996;66: 275-80.
5. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-4.
6. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54: 853-7.
7. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization-embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803.
8. Check H, Chase JS, Nowroozi K, Dietterich CJ. Premature luteinization: treatment and incidence in natural cycles. Hum Reprod 1991;6:190-3.
9. Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, Navot D. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675-9.
10. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62: 1011-7.
11. Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonado-trophin. Hum Reprod 1995;10:1060-4.
12. Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril 1996;66:873-84.
13. Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril 1995;63:1267-71.
14. Adonakis G, Deshpande N, Yates RWS, Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril 1998;69:450-3.
15. Huang FJ, Chang SY, Tsai MY, Kung FT, Wu JF, Chang HW. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation. J Assist Reprod Genet 2001;18:91-6.
16. Tsai MY, Huang FJ, Kung FT, Lin YC, Chang SY, Wu JF, Chang HW. Influence of polyvinylpyrrolidone on the outcome of intracytoplasmic sperm injection. J Reprod Med 2000;45:112-20.
17. Huang FJ, Huang HW, Lan KC, Kung FT, Lin YC, Chang HW, Chang SY. The maturity of human cumulus-free oocytes is positively related to blastocyst development and viability. J Assist Reprod Genet 2002;19:555-60.
18. Veeck LL. Preembryo grading. In: Veeck LL, ed. Atlas of the Human Oocyte and Early Conceptus, Volume 2. Baltimore, MD: Williams and Wilkins, 1991.
19. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000;73:1155-8.
20. Lan KC, Huang FJ, Lin YC, et al. The predictive value of using a combined Z-score and day 3 embryo morphology score in the assessment of embryo survival on day 5. Hum Reprod 2003;18:1299-306.
21. Huang FJ, Lan KC, Kung FT, et al. Human cumulus-free oocyte maturational profile and in vitro developmental potential after stimulation with recombinant versus urinary FSH. Hum Reprod 2004;19:306-15.
22. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-6.
23. Özçakir HT, Levi R, Tavmergen E, Göker EN. Premature luteinization defined as progesterone estradiol ratio > 1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. J Obstet Gynaecol Res 2004;30:100-4.
24. Cedars Ml, Surey E, Hamilton F, Lapolt P, Meldrum DR. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil Steril 1990;53:627-31.
25. Ron-El R. Improved pregnancy rate in IVF/ET by combined long-acting GnRH analogue and gonadotropins. In: Vickery BH, Lunenfeld B, eds. GnRH Analogues in Reproduction and Gynecology, Volume II. Dordrecht/Boston/London: Kluwer Academic Publishers, 1990:167-71.
26. Penzias AS, Shamma FN, Gutmann JN, Jones EE, DeCherney AH, Lavy G. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial. Obstet Gynecol 1992;79:739-42.
27. Stokman PGW, de Leeuw R, van den Wijngaard HAGW, Kloosterboer HJ, Vemer HM, Sanders ALM. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 1993;60:175-8.
28. Mannaerts B, de Leeuw R, Geelen J, Van Ravestein A, Van Wezenbeek P, Schuurs A, Kloosterboer H. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991;129:2623-30.
29. Shaw RW, Ndukwe G, Imoedemhe DA, Bernard AG, Burford G. Twin pregnancy after pituitary desensitisation with LHRH agonist and pure FSH. Lancet 1985;326: 506-7.
30. Gonzalez-Robayana U, Falender AE, Ochsner S, Firestone GL, Richards JS. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/ Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol 2000;14:1283-300.
31. Richards JS. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 2001;15:209-18.
32. Richards JS, Russell DL, Ochsner S, et al. Novel signaling pathways that control ovarian follicular development, ovulation and luteinization. Recent Prog Horm Res 2002;57: 195-220.
33. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, Ciampaglia W. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod 2002;17:2009-15.